|
Basic Characteristics of Mutations
|
|
Mutation Site
|
L180M |
|
Mutation Site Sentence
|
LMV-resistance mutations (L180M, M204I) were detected in a patient with subgenotype C2 who had acute self-limited hepatitis. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
P |
|
Standardized Encoding Gene
|
P
|
|
Genotype/Subtype
|
A;C |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Acute Hepatitis B
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
Lamivudine(LAM) |
|
Location
|
Japan |
|
Literature Information
|
|
PMID
|
20074155
|
|
Title
|
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains
|
|
Author
|
Hayashi K,Katano Y,Ishigami M,Itoh A,Hirooka Y,Nakano I,Yoshioka K,Yano M,Toyoda H,Kumada T,Goto H
|
|
Journal
|
Journal of gastroenterology and hepatology
|
|
Journal Info
|
2010 Apr;25(4):745-9
|
|
Abstract
|
BACKGROUND AND AIMS: Acute hepatitis caused by lamivudine (LMV)-resistant strains has not been reported, and the clinical impact of LMV-resistant strains on acute hepatitis is not known. The aim of this study was to investigate the molecular and clinical characteristics of patients with acute hepatitis B caused by LMV-resistant strains. METHODS: Forty-five patients with acute hepatitis B were studied. Hepatitis B virus (HBV) subgenotypes and LMV-resistance mutations were determined by direct sequencing of the preS and polymerase regions, respectively. RESULTS: HBV subgenotypes A2 (n = 18), B1 (n = 1), B2 (n = 3), B3 (n = 2), C1 (n = 1), C2 (n = 19) and C6 (n = 1) were detected in patients with acute hepatitis. LMV-resistance mutations were detected in two patients. LMV-resistance mutations (L180M, M204I) were detected in a patient with subgenotype C2 who had acute self-limited hepatitis. The other patient with LMV-resistance mutations (L180M, M204V) was infected with subgenotype A2 and had severe hepatitis. CONCLUSION: LMV-resistant strains are rare, but they are starting to be found in patients with acute hepatitis B. Surveillance for detecting drug-resistant HBV strains would be important for clinical practice.
|
|
Sequence Data
|
-
|
|
|